Official Name: Abbott Laboratories

Headquarters: North Chicago, IL, United States

Founded: 1888

Employees: 113,000

CEO: Mr. Robert B. Ford

NYSE: ABT -4.40%

Market Cap

$178.02 Billion

USD as of July 1, 2024

Market Cap History

Company Description

Abbott Laboratories is a multinational health care and medical devices company. Founded in 1888, Abbot manufactures medical devices including cardiovascular and neuromodulation devices, diagnostics products, branded generic medicines, and nutritional products for children and adults including Pedialyte, Similac, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT, and MitraClip.

Abbott market capitalization over time

Evolution of Abbott Laboratories market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Abbott Laboratories

Detailed Description

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Top 1-year algo backtest: +207.50%

$10,000 in July 2023 would now be $30,750 by following this algorithm daily at market close.

Boost your returns with Disfold DeepFinance... Now!

Try Disfold DeepFinance FREE

Product & Services

Branded generic medicinesMedical devicesDiagnostic assaysNutritionals

Key People

Founder(s): Dr. Wallace Calvin Abbott

Miles D. White (Executive Chairman) Robert B. Ford (President & CEO) Robert Funck (Executive Vice President & CFO)


Revenue: US$34.608 billion (2020)

Operating income: US$5.357 billion (2020)

Net income: US$4.495 billion (2020)

Total assets: US$72.548 billion (2020)

Total equity: US$33.003 billion (2020)



100 Abbott Park Road

Department 377 Building AP6A-1, Abbott park

North Chicago, IL 60064

United States

Phone: 224 667 6100